Visualisation of Sentinel Lymph Node with Indium-Based near Infrared Emitting Quantum Dots in a Murine Metastatic Breast Cancer Model

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Helle, Marion ^a,b,c   Cassette, Elsa ^d   Bezdetnaya, Lina ^a,b,c   Pons, Thomas ^d   Leroux, Agnès ^a   Plénat, François ^a   Guillemin, François ^a,b,c   Dubertret, Benoît ^d   Marchal, Frédéric ^a,b,c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM; QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST METASTASIS; CANCER MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG URINE LEVEL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LYMPH NODE; MASS SPECTROMETRY; MOUSE; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; SENTINEL LYMPH NODE; SPLEEN; TOXICITY TESTING;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; FIBROBLASTS; FLUORESCENCE; HEMOLYSIS; HUMANS; INDIUM; LYMPH NODES; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; QUANTUM DOTS; SPECTROSCOPY, NEAR-INFRARED; TIME FACTORS; TISSUE DISTRIBUTION; TOXICITY TESTS;

MURINAE; MUS;

EID: 84865583154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044433     Document Type: Article

References (47)

1. Zurrida S, Morabito A, Galimberti V, Luini A, Greco M, et al. (1999) Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol 15 (3): 475-480.
2. Bonnema J, van de Velde CJ, (2002) Sentinel lymph node biopsy in breast cancer. Ann Oncol 13 (10): 1531-1537.
3. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, et al. (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18 (13): 2560-2566.
4. Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE, (2010) Adverse reactions to patent blue V dye- The NEW START and ALMANAC experience. Eur J Surg Oncol 36 (4): 399-403.
5. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV, (2006) Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13 (12): 1671-1681.
6. Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der VorstJR, et al. (2011) Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18 (9): 2483-2491.
7. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, et al. (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16 (10): 2943-2952.
8. Hirche C, Dresel S, Krempien R, Hunerbein M, (2010) Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience. Ann Surg Oncol 17 (9): 2357-2362.
9. Hirche C, Murawa D, Mohr Z, Kneif S, Hunerbein M, (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121 (2): 373-378.
10. Hirche C, Mohr Z, Kneif S, Doniga S, Murawa D, et al. (2012) Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis 27 (3): 319-324.
11. Crane LM, Themelis G, Arts HJ, Buddingh KT, Brouwers AH, et al. (2011) Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol 120 (2): 291-295.
12. Gravier J, Navarro FP, Delmas T, Mittler F, Couffin AC, et al. (2011) Lipidots: competitive organic alternative to quantum dots for in vivo fluorescence imaging. J Biomed Opt 16 (9): 096013.
13. Murray CB, Norris DG, Bawendi MG, (1993) Synthesis and characterization of nearly monodisperse CdE (E = S, Se, Te) semiconductor nanocrystallites. J Am Chem Soc 115: 8706-8715.
14. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP, (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281 (5385): 2013-2016.
15. Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, et al. (2007) Biological applications of quantum dots. Biomaterials 28 (31): 4717-4732.
16. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, et al. (2002) Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13 (1): 40-46.
17. Pic E, Pons T, Bezdetnaya L, Leroux A, Guillemin F, et al. (2009) Fluorescence Imaging and Whole-Body Biodistribution of Near-Infrared-Emitting Quantum Dots after Subcutaneous Injection for Regional Lymph Node Mapping in Mice. Mol Imaging Biol.
18. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, et al. (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22 (1): 93-97.
19. Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JA, et al. (2007) Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 18 (2): 389-396.
20. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM, (2002) The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J 8 (4): 192-198.
21. Derfus A, Chan WCW, Bhatia S, (2004) Probing the cytotoxicity of CdSe quantum dots with surface modification. Nano Letters, 4 (1): 11-18.
22. Hardman R, (2006) A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114 (2): 165-172.
23. Riviere JE, (2009) Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1 (1): 26-34.
24. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, et al. (2007) Renal clearance of quantum dots. Nat Biotechnol 25 (10): 1165-1170.
25. Pons T, Pic E, Lequeux N, Cassette E, Bezdetnaya L, et al. (2010) Cadmium-free CuInS2/ZnS quantum dots for sentinel lymph node imaging with reduced toxicity. ACS Nano 4 (5): 2531-2538.
26. Liu YF, Yu JS, (2010) In situ synthesis of highly luminescent glutathione-capped CdTe/ZnS quantum dots with biocompatibility. J Colloid Interface Sci 351 (1): 1-9.
27. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, et al. (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17 (2): 163-170.
28. Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, et al. (2005) Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3 (1): 1-13.
29. Dreau D, Karaa A, Culberson C, Wyan H, McKillop IH, et al. (2006) Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis. Clin Exp Metastasis 23 (1): 41-53.
30. Hunter F, Xie J, Trimble C, Bur M, Li KC, (2006) Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model. Mol Cancer 5: 5.
31. Tsay JM, Michalet X, (2005) New light on quantum dot cytotoxicity. Chem Biol 12 (11): 1159-1161.
32. Chouly C, Bordenave L, Bareille R, Guerin V, Baquey A, et al. (1994) In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging. Clin Mater 15 (4): 293-301.
33. Goodman CM, McCusker CD, Yilmaz T, Rotello VM, (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15 (4): 897-900.
34. Slowing I, Wu CW, Vivero-Escoto JL, Lin VS, (2009) Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5 (1): 57-62.
35. Male KB, Lachance B, Hrapovic S, Sunahara G, Luong JH, (2008) Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy. Anal Chem 80 (14): 5487-5493.
36. Yong KT, Roy I, Hu R, Ding H, Cai H, et al. (2010) Synthesis of ternary CuInS(2)/ZnS quantum dot bioconjugates and their applications for targeted cancer bioimaging. Integr Biol (Camb) 2 (2-3): 121-129.
37. Castronovo FP, Wagner HN, (1971) Factors affecting the toxicity of the element indium. Br J Exp Pathol 52 (5): 543-559.
38. Zheng W, Winter SM, Kattnig MJ, Carter DE, Sipes IG, (1994) Tissue distribution and elimination of indium in male Fischer 344 rats following oral and intratracheal administration of indium phosphide. J Toxicol Environ Health 43 (4): 483-494.
39. Fischer H, Liu L, Pang K, Chan W, (2006) Pharmacokinetics of Nanoscale Quantum Dots In Vivo Distribution, Sequestration, and Clearance in the Rat. Advanced Functional Materials 16: 1299-1305.
40. NTP (2001) Toxicology and carcinogenesis studies of indium phosphide in F344/N rats and B6C3F1 mice (inhalation studies). U.S. department of Health and Human Services.
41. Chen HW, (2007) Exposure and health risk of gallium, indium, and arsenic from semiconductor manufacturing industry workers. Bull Environ Contam Toxicol 78 (1): 5-9.
42. Hoet P, De Graef E, Swennen B, Seminck T, Yakoub Y, et al. (2011) Occupational exposure to indium: what does biomonitoring tell us? Toxicol Lett.
43. Estourgie SH, Nieweg OE, Valdes Olmos RA, Rutgers EJ, Peterse JL, et al. (2003) Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol 29 (4): 336-340.
44. Goyal A, Douglas-Jones AG, Newcombe RG, Mansel RE, (2005) Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 11 (3): 188-194.
45. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R, (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1): 11-24.
46. Backus J, Laughlin T, Wang Y, Belly R, White R, et al. (2005) Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7 (3): 327-336.
47. Vincent-Salomon A, Caly M, De Rycke Y, Freneaux P, Klijanienko J, et al. (2009) Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma. Eur J Cancer 45 (11): 1979-1986.